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Abstract  53 
Growing up on a farm is associated with an asthma-protective effect but the underlying mechanisms 54 
are largely unknown. In the PASTURE birth cohort, we modeled maturation using 16S rRNA sequence 55 
data of the human gut microbiome in infants from 2 to 12 months. The estimated microbiome age 56 
(EMA) in infants at 12 months was associated with previous farm exposure (β=0.27 [0.12-0.43], 57 
p=0.001, n=618) and reduced risk of asthma at school age (OR=0.72 [0.56-0.93], p=0.011). EMA 58 
mediated the protective farm effect by 19%. In a nested case-control sample (n=138), we found 59 
inverse associations of asthma with measured level of fecal butyrate (OR=0.28 [0.09-0.91], p=0.034), 60 
bacterial taxa predicting butyrate production (OR=0.38 [0.17-0.84], p=0.017), and the relative 61 
abundance of the gene encoding butyryl-CoA:acetate CoA-transferase, a major enzyme in butyrate 62 
metabolism (OR=0.43 [0.19-0.97], p=0.042). The gut microbiome may contribute to asthma 63 
protection through metabolites, supporting the concept of a gut-lung axis in humans. 64 
Introduction 65 
Many adult diseases originate early in life.1 In the prenatal period, environmental influences on 66 
disease development are filtered by the maternal organism. After birth, however, the infant interacts 67 
directly with the environment, beginning with the colonization of the body surfaces by microbiota 68 
within the first hours of life.2 This process consists of mutual adaptation between host and 69 
microbiota and ultimately educates the host’s immune system.3 Studies in gnotobiotic mice support 70 
an essential role for microbial exposure in the development of the immune system.4 The inverse 71 
relation of microbial exposure and immune-mediated diseases such as allergies and asthma has been 72 
the basis for the hygiene hypothesis and its amendments explaining the epidemics of inflammatory 73 
diseases in a world that has abandoned traditional lifestyles.5  74 
A proposed mechanism by which a traditional lifestyle may grant strong protective effects against 75 
asthma involves the sustained microbial exposure on farms.6,7 This protective effect has mainly been 76 
attributed to consumption of farm milk and exposure to a variety of environmental microbiota in 77 
animal sheds.6,8  78 
A highly diverse microbial environment may influence the human microbiome and thus mitigate 79 
asthma risk, as shown for the microbiome of the upper airways.9,10 For the gut microbiome, the 80 
effect on airway disease is less obvious. Murine models have suggested protection from allergic 81 
inflammation in the lung through metabolites such as short chain fatty acids (SCFA) produced by 82 
certain gut bacteria.11 83 
The human gut microbiome undergoes profound changes during the first year of life and starts 84 
stabilizing thereafter.12,13 Hence, we hypothesized that particularly the first year of life represented a 85 
time window for exposures of the outer environment to shape the development of the human 86 
microbiome with possibly lasting consequences. The large population-based PASTURE birth cohort 87 
provided the unique opportunity to comprehensively assess farm-related environmental effects on 88 
the early gut microbiome and, through the gut microbiome, on respiratory health. 89 
Results 90 
The Protection against Allergy—Study in Rural Environments (PASTURE) birth cohort followed 91 
children in European rural areas, of whom 50% were born to mothers living on a family-run farm. In 92 
the Austrian, Finnish, German, and Swiss arms of this study (n=930, 49% females), fecal samples 93 
were taken at month 2 and month 12. At both time points, we obtained sequence reads for the 94 
bacterial 16S rRNA and the fungal internal transcribed spacer (ITS) region from samples from 618 95 
(66%) and 189 (20%) children, respectively, which represented all four centers at similar shares 96 
between 22% and 33% (Extended Data Fig. 1, Supplementary Table 1). Asthma was defined as a 97 
physician’s diagnosis of asthma or recurrent obstructive bronchitis established until 6 years of age 98 
and was present in 8.1% of the 930 children. 99 
Bacterial composition at month 2 and 12 100 
At month 2 (Fig. 1a), the genus Bifidobacterium was predominant. Despite a positive association of 101 
the relative abundance of Bifidobacterium with breastfeeding (β=0.43 [0.23; 0.64], p<0.001), this 102 
genus was not significantly related to subsequent asthma. At month 12 (Fig. 1b), the relative 103 
abundance of Bifidobacterium halved, whereas the genus Blautia of the family Lachnospiraceae 104 
increased substantially in relative abundance. In addition, various other genera including 105 
Coprococcus, Faecalibacterium, and Roseburia became detectable. By clustering bacterial 106 
composition over both time points by Dirichlet mixture modeling, we identified 5 clusters (DCs), with 107 
two clusters mainly representing the month 2 samples, two representing the month 12 samples and 108 
one cluster shared by both time points (Fig. 1c,d). The first two clusters (DC1 and DC2) were 109 
dominated by Bifidobacterium, whereas the third cluster (DC3) revealed considerable heterogeneity 110 
between samples with various different taxa accounting for at least 1% relative abundance (Fig. 1c, 111 
Supplementary Table 2). DC4 and DC5 demonstrated more stabilized bacterial patterns with the 112 
emergence of Firmicutes. In samples of month 12, children in this cluster showed a higher prevalence 113 
of asthma as compared to clusters DC4 and DC5 (Fig. 1e).  114 
Microbial maturation 115 
To better understand the physiologic changes of the gut microbiome during the first year, we 116 
modeled the exact age of fecal sampling by a random forest of the composition of bacterial genera at 117 
month 2 and 12 in individuals with samples available at both time points. Since this model estimates 118 
the biological age of the healthy microbiome, we termed the resulting prediction score ‘estimated 119 
microbiome age’ (EMA). To exclude interference with disease, we restricted the model building to 120 
133 healthy individuals (67 farm children and 66 non-farm children) without diarrhea between 121 
month 2 and 12 and never affected by wheeze or asthma.  122 
The taxa most importantly contributing to the prediction model were Blautia and Coprococcus (Fig. 123 
2a). When applying the prediction model to the entire population (n=618), the composition of genera 124 
did not vary notably with EMA at month 2 (Fig. 2b), whereas at month 12 a clear pattern emerged 125 
with an increase particularly in Ruminococcus, Roseburia, and Coprococcus (Fig. 2c). When stratifying 126 
for month 2 and 12 samples, the correlation of EMA with the exact sampling time point was largely 127 
removed (Fig. 2d, rho=0.10 and rho=0.15 for the month 2 and 12 samples, respectively), thereby 128 
indicating that EMA essentially reflects maturation from 2 to 12 months. DC3 comprised month 2 129 
samples with advanced and month 12 samples with delayed EMA (Fig. 2d) thereby describing 130 
individuals not following typical maturation. As an alternative surrogate for maturation we explored 131 
a PCoA over both time points (Extended Data Fig. 2a), whose first axis strongly correlated with EMA 132 
(Extended Data Fig. 2b). 133 
Children with any asthma displayed on average significantly lower EMA values at month 12 (Fig 2e). 134 
The prevalence of asthma was 12% in children with incomplete maturation as defined by the lowest 135 
quartile of EMA (Fig. 2e). Children with more advanced EMA had a lower risk of asthma (OR=0.48 136 
[0.25-0.93], p=0.030) and lung function impairment (OR=0.48 [0.27-0.82], p=0.008), when compared 137 
against the lowest quartile of EMA. Similarly as a continuous variable, higher EMA reduced the risk of 138 
asthma (OR=0.72 [0.56-0.93], p=0.011) and particularly of non-atopic asthma (Fig. 2f). The effect of 139 
EMA on asthma was not changed when adjusted for DC3 at month 12, whereas the effect of DC3 on 140 
asthma was largely removed when adjusting for EMA (Fig. 2f). The effect of EMA was more 141 
pronounced in carriers of the non-risk genotype encoded on chromosome 17q21 (Supplementary 142 
Table 3) and was also seen in a sensitivity analysis excluding the 133 children in whom the prediction 143 
model was established (Extended Data Fig. 2c/d). When predicting EMA at month 2, there was no 144 
clear association with asthma (OR=1.24 [0.93-1.65], p=0.135). 145 
Microbial maturation versus composition 146 
We analyzed microbial composition using a principle components analysis (PCA) approach designed 147 
for compositional data. At month 2, the 3rd PCA-axis exerted an asthma-protective effect (OR=0.68 148 
[0.49-0.95], p=0.024) irrespective of concomitant atopy (Extended Data Fig. 3a). This axis correlated 149 
with the relative abundance of Bacteroides and Parabacteroides and inversely with Enterococcus 150 
(Extended Data Fig. 3b).  151 
At month 12, the 1st PCA-axis was inversely related to non-atopic asthma (OR=0.62 [0.39-1.00], 152 
p=0.048) and correlated particularly with Roseburia, Ruminococcus, and Faecalibacterium (Extended 153 
Data Fig. 3c,d). A sensitivity analysis based on principle coordinate analysis (PCoA) using unweighted 154 
UniFrac as distance measurement corroborated these patterns (Extended Data Fig. 4). 155 
EMA correlated strongly with PCA-axis 1 at month 12 (rho=0.75) and α-diversity (rho=0.70 for 156 
richness), but not with PCA-axis 3 at month 2 (Extended Data Fig. 5). EMA and PCA-axis 3 at month 2 157 
emerged as independent determinants of asthma in a mutually adjusted model (Extended Data Fig. 158 
3e-g), whereas the effect of PCA-axis 1 at month 12 was explained by EMA.  159 
Estimated microbiome age and the farm effect on asthma 160 
The PASTURE study was designed to assess the farm effect on asthma (OR=0.53 [0.30-0.92], p=0.023, 161 
n=930). In the present subpopulation (n=618), farm children also had a lower risk of asthma as 162 
compared to rural nonfarm children (center-adjusted OR=0.56 [0.29-1.08], p=0.082). At month 2, no 163 
effect of farm exposure on the microbial composition was seen, while the asthma-protective PCA-164 
axis 3 was positively associated with breastfeeding and inversely with C-section and maternal 165 
smoking during pregnancy (Fig. 3a) independently from gestational age. In contrast, EMA was 166 
delayed by prolonged breastfeeding (Extended Data Fig. 6) but positively influenced by growing up 167 
on a farm (β=0.27 [0.12-0.43], p=0.001) and particular farm exposures such as stays in animal sheds 168 
or consumption of milk or eggs directly obtained from a farm (Fig. 3b). The latter variables also 169 
reflect a more diverse feeding pattern in farm children, as illustrated by a more frequent 170 
consumption of all six main food items cereals, meat, bread, yogurt, cake, and vegetables / fruits 171 
(Supplementary Table 4). A sensitivity analysis showed independent effects on EMA by a diverse 172 
feeding pattern (β=0.18 [0.01; 0.34], p=0.034) and prolonged breastfeeding (β=-0.41 [-0.62; -0.21], 173 
p<0.001). Farm children were allocated more commonly to the more advanced Dirichlet clusters DC4 174 
and DC5 at month 12 (p<0.001, Fig. 3c).  175 
The effect of EMA at month 12 on asthma was validated in 102 additional PASTURE children, i.e. 176 
individuals without measurements at month 2 (Fig. 3d). This effect was also consistent over the study 177 
centers, as was the effect of farm exposure on EMA (Fig. 3e,f). The effect of EMA withstood 178 
adjustment for the childhood asthma locus on chromosome 17q21 and potential confounders 179 
(Supplementary Table 5).  180 
A structure equation model revealed that EMA mediated the asthma-protective effect of growing-up 181 
on a farm by 19% (p=0.011, Fig. 3g), also in children of non-asthmatic mothers (25%, p=0.024). 182 
Likewise, PCA-axis 3 at month 2 tended to mediate the asthma-protective effect of breastfeeding by 183 
18% (p=0.100). Farm children were characterized by a more mature microbiome including 184 
Coprococcus and Roseburia (Fig. 3h), known producers of short chain fatty acids (SCFA). 185 
Bacterial metabolites and estimated microbiome age 186 
To assess bacterial taxa by their capacity to produce SCFA, we modeled SCFA measurements 187 
obtained at month 12 in 209 children by the composition of bacterial genera using random forest 188 
models. Production of butyrate, propionate, and acetate was most importantly predicted by 189 
Roseburia, Bacteroides, and Turicibacter, respectively (Fig. 4a). 190 
Since the SCFA prediction scores were correlated mutually and partially with EMA, we performed a 191 
four-dimensional PCA on EMA and the SCFA scores (Fig. 4b, n=720). Both the butyrate score and EMA 192 
loaded on dimension (Dim) 1, which was inversely associated with asthma and non-atopic asthma 193 
(Fig. 4c). The acetate score loaded particularly on Dim 2, which was unrelated to asthma. Dim 3 194 
represented the propionate score and partially EMA and was inversely related to atopic asthma. Dim 195 
4 mainly reflected the difference between EMA and the butyrate score and had an additional 196 
protective effect on non-atopic asthma. 197 
Dim 1 and 3 (representing EMA, butyrate and propionate scores) were positively related to growing 198 
up on a farm and particularly consumption of unprocessed farm milk (Fig. 4d). Dim 1 mediated 15% 199 
and Dim 3 an additional 6% of the farm effect on asthma (Fig. 4e). 200 
In a nested case-control sample (44 cases and 94 controls), we validated the butyrate score as the 201 
most relevant SCFA score. For this purpose we determined by qPCR the relative abundance of the 202 
gene encoding a major bacterial enzyme in the butyrate metabolism, i.e. butyryl-CoA:acetate CoA-203 
transferase. When comparing the results of this gene assay with the originally measured butyrate 204 
levels and the estimated butyrate score we found particularly high asthma prevalence figures in the 205 
lowest quartiles of the respective measures (Fig. 4f). The corresponding associations with the 206 
different asthma phenotypes were similar for all measures (Fig. 4g), e.g. OR with asthma = 0.28 [0.09-207 
0.91], p=0.034 for measured level, 0.38 [0.17-0.84], p=0.017 for butyrate score, and 0.43 [0.19-0.97], 208 
p=0.042 for the gene assay. Likewise, the associations of the asthma phenotypes with the propionate 209 
score resembled those with the corresponding measured levels in the same case-control sample 210 
(Extended Data Fig. 7). 211 
Network of bacteria versus single taxa 212 
Focusing on the result of the maturation process, i.e. the microbial composition and interrelation of 213 
the genera at 12 months, we performed a network analysis (Fig. 5a). This revealed five network 214 
modules with three hubs, which were closely connected. Two hubs reflected Roseburia and 215 
Ruminococcus and belonged to the green module, whose first eigenvector was correlated with EMA 216 
(r=0.73) and the butyrate score (r=0.68). The yellow module was moderately related to EMA (r=0.35) 217 
and contained two main taxa of EMA, i.e. Blautia and Coprococcus; the latter formed the third hub.  218 
When exploring the association of asthma with amplicon sequence variants (ASVs) related to the 219 
three hubs, two asthma-protective ASVs, one of genus Roseburia (OR=0.42 [0.18-1.01], p=0.053) and 220 
one of the genus Coprococcus (OR=0.38 [0.16-0.92], p=0.032) emerged (Supplementary Table 6). 221 
Using 16S ribosomal sequences database BLAST, the first ASV was more precisely assigned to 222 
Roseburia inulinivorans (100% identity), whereas the second ASV was more compatible with 223 
Anaerobutyricum hallii (98.4%) than Coprococcus eutactus (92.4%). Presence of these ASVs was 224 
strongly related to higher butyrate levels (GMR=1.76 [1.34-2.32], p<0.001 and 1.52 [1.12-2.05], 225 
p=0.008, respectively) and relative abundance of the butyryl-CoA:acetate CoA-transferase gene 226 
(GMR=3.33 (1.55-7.15), p=0.003 and 3.81 (1.74-8.34), p=0.001, respectively). The associations of 227 
these ASVs with asthma, however, did not withstand adjustment for EMA. Likewise, no genus was 228 
found with an independent protective effect on asthma (Supplementary Table 7), whereas 229 
Eggerthella (red module) exerted a particular risk effect on asthma (1.43 [1.07-1.92], p=0.016) 230 
independently from EMA. 231 
The mycobiome and fungal age 232 
In addition to bacteria, we further explored fungal colonization using ITS-data (n=189, Extended Data 233 
Fig. 1). Estimated fungal age (EFA) was calculated in analogy to EMA and mainly depended on 234 
changes in Saccharomyces, Alternaria, and Malassezia. EFA was determined by consumption of 235 
starchy foods and unrelated to subsequent asthma (Extended Data Fig. 8). Though EFA and EMA 236 
were uncorrelated (rho=0.02), relative abundance of the highly prevalent genus Alternaria at 2 237 
months was associated with subsequent bacterial maturation (β=0.05 [0.01-0.10], p=0.032).  238 
Sensitivity analyses 239 
EMA was also inversely associated with an asthma diagnosis established after 3 years of age 240 
(Extended Data Fig. 9) and particularly with the less common (Supplementary Table 8) persistent 241 
wheeze phenotype (OR=0.49 [0.35-0.70], p<0.001).14 EMA was unrelated to sensitization to seasonal, 242 
perennial, or food allergens. Stratification for atopic sensitization in children or for maternal asthma 243 
did not reveal major differences in the associations of asthma phenotypes with EMA (Supplementary 244 
Table 9). Similarly, the associations of EMA and asthma phenotypes were homogeneous between 245 
farm and non-farm children with the exception of the association of EMA and atopic asthma, which 246 
was only seen in non-farm children (0.68 [0.45-1.02], p=0.060). Unlike microbial maturation and 247 
composition, the butyrate score did not significantly vary between centers (p=0.191, Extended Data 248 
Fig. 10). 249 
Discussion 250 
In the PASTURE birth cohort, farm-related exposures influenced the maturation of the gut 251 
microbiome during the time window from 2 to 12 months. As a measure of maturation, estimated 252 
microbiome age (EMA) mediated a substantial proportion of the well-known farm effect on asthma. 253 
Bacterial communities with the potential of producing butyrate such as Roseburia and Coprococcus 254 
contributed to asthma protection (Fig. 5b). 255 
Mode of birth has often been associated with the subsequent colonization of the human gut, as 256 
exemplified for Bacteroides.12 The relevance of mode of birth for future health15 highlights the role of 257 
the maternal microbiome in the colonization of the neonatal gut. The current analyses, however, 258 
suggest that this maternal influence is gradually replaced by the increasing variety of environmental 259 
exposures affecting the growing child. Indeed, the most influential change in the development of the 260 
mammalian gut microbiome is probably the transition from breastfeeding to solid food.16,17 261 
bifidobacteria, whose early predominance may be fostered by the bifidogenic properties of 262 
breastmilk,18 decrease after weaning. In our analysis, the asthma-protective PCA-axis at month 2 was 263 
mainly influenced by mode of birth and correlated with Bacteroides. The positive association of this 264 
axis with breastfeeding and its asthma-protective effect was not explained by bifidobacteria. 265 
Independently from this very early phenomenon, bacterial maturation between month 2 and 12 266 
exerted a strong protective effect on asthma. Various shifts in bacterial composition including the 267 
bacterial families Lachnospiraceae, Ruminococcaceae, and Bifidobacteriaceae suggest high plasticity 268 
of the intestinal microbiome throughout the first year of life.12,13 Evidently, the window of 269 
opportunity for the establishment of an asthma-protective microbiome extends substantially beyond 270 
the well-studied19-21 period of the first 3 months of life. Early precipitate maturation might even be 271 
unfavorable for asthma,22 which may explain the tendency towards asthma risk by higher EMA values 272 
at month 2, particularly in children assigned to DC3. 273 
EMA predicted asthma better than DC3 at any time point, emphasizing the developmental aspect of 274 
a favorable microbiome. Possibly the bacterial composition is not beneficial by itself but may indicate 275 
successful maturation. This notion has vast implications for prevention strategies as the mere 276 
application of distinct probiotics or combinations thereof seems less promising for asthma 277 
prevention. 278 
In contrast to the early microbiome, which was favorably influenced by breastfeeding, the 279 
subsequent maturation process was hampered by prolonged breastfeeding. Since the effect of 280 
prolonged breastfeeding on EMA was independent from the diversity of solid foods, this finding 281 
supports the idea that cessation of breastfeeding is a key factor for microbial composition and 282 
maturation.12,16,17 283 
The particular setting of the PASTURE study revealed other main determinants of maturation, which 284 
were all related to farm exposure, the epitome of the hygiene hypothesis. Farm children are known 285 
to be exposed to a larger variety of environmental microbiota6 and potentially beneficial clusters of 286 
microorganisms.23 There may be various mechanisms involved in the mediation of the protective 287 
effect of environmental microbiota on asthma: when playing in animal sheds, e.g., children may 288 
inhale environmental microorganisms, which may exert their effects directly in the airways.9,10 In the 289 
present mediation analysis, we demonstrate that 19% of the farm effect on asthma was mediated 290 
through the maturation of the gut microbiome, suggesting that environmental microbiota are 291 
ingested and interact with the gut microbiome. At least, this notion is a reminder of the feco-orally 292 
transmitted infections postulated as protective by the hygiene hypothesis.5 The remaining 81% of the 293 
farm effect on asthma might be mediated by other mechanisms, operating also beyond the first year 294 
of life. 295 
When exploring a single taxa approach, we did not identify any taxon as protective in itself.  This was 296 
unlikely to be caused by insufficient statistical power, since we detected a risk effect by the single 297 
taxon Eggerthella, an emerging pathogen with asthma risk effects in adults.24,25 Likewise in the nasal 298 
microbiome we previously identified individual taxa such as Moraxella catharralis merely as being 299 
harmful.10 Accordingly, single taxa are more likely to exert harm effects.  300 
Inconsistencies between studies may arise from differences in time point of sampling. For example, 301 
risk of atopic wheeze was associated with relative abundance of the taxa Faecalibacterium sp., 302 
Lachnospira sp., Veillonella sp., and Rothia sp. at 3 months but not at 12 months.20 The beneficial 303 
taxon Veillonella may not only lose its beneficial effect over time,26 but even emerge subsequently as 304 
an asthma-risk taxon.27 Though Bacteroides, Prevotella and Coprococcus were associated with allergic 305 
diseases from 6 months to 8 years, other taxa such as Ruminococcus have been shown to lose their 306 
beneficial effect within the first year.28 Though Bifidobacterium has been suggested as a beneficial 307 
probiotic in other contexts,29 it was increased in allergic children at later time points.28 In our 308 
analysis, Bifidobacterium did not contribute to the asthma-protective effect. These inconsistencies 309 
were another reason for our integrative approach considering changes in bacterial composition over 310 
time.  311 
A limitation of the current analysis might be seen in only two sampling time points, possibly missing 312 
fluctuations within this developmental window. Nevertheless, this drawback might emerge as an 313 
advantage, as comparing starting point and outcome of the core maturation process may highlight 314 
the essential changes of the microbiota in this time window. Further refinement occurs in the 315 
subsequent years12,13 and, on a smaller scale, throughout life.22,30 Another limitation is that parent-316 
reported diagnosis of asthma is susceptible to misclassification; in previous analyses, however, this 317 
outcome definition has been validated by lung function measurements.14 318 
To better understand how bacterial maturation may impact respiratory health we focused on the 319 
functional properties of the gut bacteria and modelled communities with a high likelihood of 320 
producing distinct SCFAs. As all resulting SCFA scores were correlated with EMA, we tried to 321 
disentangle the different aspects of EMA and the three SCFA scores by a PCA. The component of 322 
EMA that was shared with the likelihood of producing butyrate (Dim 1) exerted the strongest 323 
asthma-protective effect, predominantly for the non-atopic phenotype. For the atopic phenotype the 324 
aspect of EMA shared with propionate production (Dim 3) was particularly relevant. Moreover, both 325 
aspects were involved in the mediation of the protective farm effect on asthma. In contrast, the 326 
likelihood of producing acetate, which predominantly represented Dim 2, was unrelated to asthma. 327 
This finding might argue in favor of a specific effect of butyrate and propionate in the human setting, 328 
where these SCFA, but not acetate, have been shown to impair viability of eosinophils.31 Finally, Dim 329 
4 denoted an aspect of EMA that was not shared with butyrate production; hence, bacterial 330 
maturation may exert an individual protective effect on non-atopic asthma beyond butyrate 331 
production. 332 
In order to validate the relevance of SCFA production we related asthma directly to SCFA levels as 333 
measured in the fecal samples32 and found consistent associations with butyrate and a tendency for 334 
an association between atopic asthma and propionate. The gene assay targeting the main pathway 335 
of the bacterial butyrate metabolism, i.e. conversion of butyryl-CoA to butyrate via butyryl-336 
CoA:acetate CoA-transferase,33 corroborated the association of butyrate production and (non-atopic) 337 
asthma. 338 
Butyrate is the main source of energy for colon epithelial cells, contributes to the maintenance of the 339 
epithelial gut barrier, and has immunomodulatory and anti-inflammatory properties.34 Various taxa, 340 
whose composition considerably varies between individuals, can contribute to butyrate production 341 
directly and by cross-feeding.35 Likewise, propionate has an anti-inflammatory potential, but is 342 
mainly produced by intestinal Bacteroides taxa, though also some Roseburia, Coprococcus, and 343 
Blautia taxa can switch from butyrate to propionate production.36 In particular Roseburia has been 344 
suggested as a biomarker of health because of its anti-inflammatory properties.37  345 
We found two promising asthma-protective ASV candidates of the genera Roseburia and 346 
Coprococcus (or A. hallii), which were also directly related to butyrate production and the butyryl-347 
CoA:acetate CoA-transferase gene. Adjustment for EMA, however, revealed that these taxa do not 348 
carry the asthma-protective effect themselves. Rather they may represent a network of bacteria with 349 
the capacity to produce SCFA. This notion is supported by the role of the genera Roseburia and 350 
Coprococcus as hubs in the network analysis. 351 
Altogether, higher SCFA levels may reduce inflammation at various body sites including the airway 352 
mucosa. The effect of butyrate- and propionate-producing bacteria reflects an aspect of healthy 353 
maturation of the gut microbiome and adds an independent component to the asthma-protective 354 
EMA effect, thereby extending the concept of the gut-lung axis38,39 to the human setting.  355 
The beneficial effect of gut microbiota may not be specific to respiratory health. Bacteria related to 356 
maturation of the gut microbiome (Ruminococcus, Faecalibacterium, Roseburia, and 357 
Lachnospiraceae) were also identified in children with a low prevalence of enteric infections.40 358 
Moreover, a lower abundance of Roseburia was also seen in rheumatoid arthritis.41 Hence, the 359 
combination of the above taxa might be seen as a marker of a well-established host immune system 360 
and good general health in the absence of intestinal dysbiosis.42 361 
The definition of phenotypes of asthma and atopy may vary over studies. Some studies focused on 362 
early outcomes;20,21,26 few studies followed-up for atopic wheeze43 or an asthma diagnosis27 at age 5 363 
years, when it can be established with reasonable certainty. Therefore we assessed various asthma 364 
phenotypes defined by wheezing patterns or concomitant atopy. EMA was consistently associated 365 
with the non-atopic phenotype of asthma and persistent wheeze but not with atopic sensitization 366 
per se. A family history of atopy, however, did not influence the susceptibility to the microbiome-367 
associated farm effect on asthma. In contrast to the COPSAC 2010 study,27 we found an inverse 368 
association of EMA and asthma also in children of mothers without asthma. Therefore, studies 369 
focusing on atopic outcomes like atopic wheeze20,43 or performed in high-risk populations27 might 370 
reveal other facets of the microbial effect on asthma. The current analysis points towards an 371 
inflammatory pathology beyond atopy, supported by the anti-inflammatory properties of butyrate.44 372 
Certainly butyrate is just an example and may be a marker of other metabolites that might be 373 
directly involved in signaling between intestinal and respiratory mucosa, such as D-tryptophan.45 374 
Microbial carbohydrate metabolism has also been implied in the health effects of the gut 375 
microbiome.46 In addition, the vagus nerve can sense microbial metabolites with its afferent fibers 376 
and contribute to inflammation by a low tone of its efferent part, as illustrated for inflammatory 377 
bowel disease.47 In analogy to the so-called gut-brain axis,48 the vagus nerve may also be involved in 378 
neuro-immune crosstalk49 and in communication between the gut microbiome and the airway tone, 379 
as suggested by the EMA effect on lung function. 380 
Taken together, we found strong influences of an environment rich in microbial stimuli on the 381 
maturation of the gut microbiome. Maturation and prediction of butyrate production mediated 382 
partially the well-known asthma-protective farm effect, thereby suggesting a gut-lung axis in 383 
humans. In contrast, atypical microbial maturation may contribute to the pathogenesis of 384 
inflammatory diseases. This emphasizes the need for prevention strategies in the first year of life, 385 
when the gut microbiome is highly plastic and amenable to modification.  386 
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 577 
Figure legends 578 
Figure 1: Composition of the bacterial gut microbiome at month 2 and 12 579 
a,b. Log-scaled boxplots for relative abundance in 618 children at 2 and 12 months, respectively. 580 
Lower and upper hinges of the boxes denote the first and third quartiles, respectively; the bold 581 
central line represents the median; the whiskers extend to the most extreme data point within 1.5 582 
times the interquartile range from the hinges; extreme values lie beyond the whiskers and are 583 
marked by circles. If names are in brackets, the respective bacterial genus shows a relative 584 
abundance < 0.5% at the respective time point. ‘(F)’ stands for unclassified genus of the respective 585 
bacterial family. c. Log-scaled heat map for relative abundance of genera within the 5 clusters of a 586 
Dirichlet multinomial mixture modeling analysis across both time points resulting in 2 times 618 587 
samples. d. Transition of all 618 individuals between the Dirichlet clusters (DC) from month 2 to 588 
month 12 e. Prevalence of asthma (with standard error bars, n=618) within the most prevalent 589 
clusters at month 2 and at month 12, respectively. 590 
Figure 2: Estimated microbiome age (EMA) as a measure of maturation of the gut 591 
microbiome 592 
a. Variable importance in the prediction model of estimated microbiome age (EMA) in the 133 593 
healthy individuals. b. Stacked bar plots of relative abundance of main genera plotted against 594 
increasing EMA values. The individual samples (n=618 for each time point) are ordered by increasing 595 
EMA, the genera are ordered by Spearman’s correlation with change in relative abundance between 596 
month 2 and 12. c. Spearman’s correlation of EMA at month 12 with change in relative abundance 597 
between month 2 and 12 in 618 children. The color code corresponds to panel b. Correlation p-598 
values were below 0.05 except for Escherichia to Bacteroides. d. Scatter plot for chronological age at 599 
fecal sampling against EMA at both time points (n=2 x 618). The color code reflects grouping by 600 
Dirichlet clusters over both time points. All subsequent analyses relate only to EMA at month 12. e. 601 
Scatter plot for chronological age at fecal sampling against EMA at month 12. The color code reflects 602 
asthma status at age 6 years. The red and blue lines denote average values for chronological age 603 
(horizontal) and EMA (vertical) by asthma status. Distribution of EMA values and estimated density 604 
curve is given on top of the scatter plot (n=618); the vertical line denotes the lowest quartile, i.e. 10.6 605 
months. f. Association of asthma phenotypes with Dirichlet clusters (left panel) and EMA values (right 606 
panel). Odds ratios are derived from logistic regression models (n=544 children with data on asthma). 607 
Simple models are only adjusted for center, mutually adjusted models are adjusted for center and 608 
the other microbial variable, i.e. EMA in the model for Dirichlet clusters and vice versa (A. = Asthma).   609 
Figure 3: Estimated microbiome age and the farm effect on asthma 610 
a. Bivariate associations of environmental determinants and the asthma-protective PCA-axis 3 at 611 
month 2 (n=618); colored bars denote determinants in the forward selection model. b. Bivariate 612 
associations of environmental determinants and the estimated microbiome age (EMA); colored bars 613 
denote determinants in the forward selection model. c. Transition of the 618 individuals between the 614 
previously defined Dirichlet clusters (DC) stratified by farming status. d. Meta-analysis for the effect 615 
of EMA on asthma in the 618 children with fecal samples at 2 and 12 months and in the 102 children 616 
with fecal samples only at 12 months. For 626 of these 720 children data on asthma were available. 617 
e. Meta-analysis of the effect of EMA on asthma over the study centers (n=720 children; Austria 173, 618 
Switzerland 209, Germany 176, Finland 162). f. Meta-analysis of the effect of growing up on a farm 619 
on EMA over the study centers (n=720 children, center distribution as in e). g. Mediation analysis of 620 
the protective effect of farming on asthma mediated by the estimated microbiome age (EMA, 621 
n=626). Shown are the estimates of the path model for indirect and direct effects; the proportion of 622 
the mediated (indirect) effect was 19%. h. Associations of growing up on a farm with the 20 topmost 623 
single genera (n=720, Pseudor. = Pseudoramibacter). 624 
Figure 4: Bacterial metabolites and estimated microbiome age 625 
a. Variable importance for the prediction scores of the short chain fatty acids (SCFA) butyrate, 626 
propionate, and acetate, as modeled in 209 children with measured values. b. Principle component 627 
analysis (PCA) for estimated microbiome age (EMA) and the three SCFA scores (n=720). For 628 
illustrative purposes, Dimension (Dim) 3 is plotted against Dim 1 and Dim 4 against Dim 2. Explained 629 
variance is given in brackets. c. Associations of asthma phenotypes with the four PCA dimensions. d. 630 
Associations of growing up on a farm and consumption of farm milk with the four PCA dimensions. e. 631 
Mediation analysis of the protective effect of farming on asthma mediated by the four PCA 632 
dimensions (n=626). Shown are the estimates of the path model for indirect and direct effects; the 633 
proportion of the mediated (indirect) effect was 23%. f. Validation of the butyrate score in a case-634 
control subsample of 138 children (44 asthma cases and 94 healthy controls). Proportion of asthma 635 
cases (with standard error bars) is given within quartiles of the originally measured butyrate level, 636 
the estimated butyrate score, and the gene assay, i.e. the relative abundance values of the gene for 637 
butyryl-CoA:acetate CoA-transferase, an enzyme of the bacterial metabolic pathway for butyrate 638 
production. g. Associations of asthma phenotypes with the originally measured butyrate level, the 639 
estimated butyrate score, and the gene assay, all dichotomized at the lowest quartile. 640 
Figure 5: Network of single taxa and summary of findings 641 
a. Network analysis of single genera (n=720). The resulting 5 modules are marked by different colors 642 
of the nodes. Positive correlations are marked by blue, negative correlations by red edges. Thickness 643 
of edges denotes strength of SparCC correlation ranging from -0.2 to +0.5. Only correlations with an 644 
absolute value of at least 0.2 are shown. Network hubs as defined by an eigenvector centrality value 645 
above the 99th percentile are marked by black circles.  646 
b. Summary of findings. At month 2, the intestinal microbiome was mainly determined by pre-, peri-, 647 
and early postnatal influences such as prenatal smoke exposure or its absence, mode of birth, and 648 
breastfeeding. An inverse association with asthma at school age was found for a principle component 649 
at month 2. The maturation of the microbiome from 2 to 12 months was quantified by ‘estimated 650 
microbiome age’ (EMA), a prediction score derived from a random forest of sampling time point in 651 
relation to changes in the composition of bacterial genera over time. This EMA mediated the 652 
protective farm effect on asthma by about a fifth. At month 12, the resulting intestinal microbiome 653 
formed distinct network modules with Roseburia, Ruminococcus, and Coprococcus as hubs. EMA 654 
correlated with two dimensions of a principle component analysis combining EMA and short-chain-655 
fatty acid scores. These two dimensions almost exclusively explained the mediation of the protective 656 
farm-effect on asthma and mainly represented bacterial producers of butyrate and propionate, 657 
respectively. 658 
Tables 659 
No tables in main text. 660 
Online Methods 661 
Study population  662 
The Protection against Allergy—Study in Rural Environments (PASTURE) birth cohort has been 663 
recruited in rural areas of Austria, Finland, France, Germany, and Switzerland with the aim to explore 664 
protective effects of growing up on a farm on asthma.50 Detailed information on the study design can 665 
be found in the Life Sciences Reporting Summary. Briefly, adult pregnant women were invited to 666 
participate during their third trimester; half of them lived on family-run livestock farms. Their 667 
children were recruited at birth and seen at 2, 12, 56, and 72 months during home visits. Additional 668 
questionnaires were completed at 2, 12, 18, 24, 36, 48, 60 and 72 months.  669 
Additional detailed information on the children’s health, nutrition, and farm-related exposures was 670 
gathered by using weekly diaries and monthly questionnaires covering the 9th to 52nd weeks of 671 
life.51,52 Stool samples were collected from the child’s napkin at the 2- and 12-month home visits. 672 
Because fecal sampling was not performed by design in the French arm, these children were 673 
excluded from the current analyses a priori. All aspects of the study were approved by the local 674 
institutional review boards in each country (Austria: Ethikkommission für das Land Salzburg; Finland: 675 
The Research Ethics Committee, Hospital District of Northern Savo; Germany: Ethik-Kommission der 676 
Bayerischen Landesärztekammer; Switzerland: Kantonale Ethik-Kommission St. Gallen; France: 677 
Comité Consultatif pour la Protection des Personnes en Recherche Biomédicale (CCPPRB) 678 
Commission Informatique et Libertés (CNIL)). Written informed consent was obtained from the 679 
parents or guardians.  680 
Definition of health outcomes 681 
Asthma was defined as a physician’s diagnosis of asthma at least once until 6 years or recurrent 682 
diagnoses of spastic, obstructive, or asthmatic bronchitis as reported by the parents at age 6 years.14  683 
For a sensitivity analysis we defined ‘asthma after 3 years’ as an asthma diagnosis established in the 684 
4th, 5th, or 6th year of life. Wheeze phenotypes were derived from a latent class analysis as 685 
described previously.14 686 
Allergen-specific IgE was assessed at 6 years. Seasonal IgE was defined as at least one specific IgE to 687 
alternaria, alder, birch, hazel, grass pollen, rye, mugwort, or plantain≥0.7 IU/ml at age 6 years. 688 
Perennial IgE (D. pteronyssinus, D. farinae, cat, horse, dog) and food IgE (hen's egg, cow's milk, 689 
peanut, hazelnut, carrot and wheat flour) were defined in analogy. Assessment was done in 690 
peripheral blood by using the semi-quantitative Allergy Screen test panel for atopy (Mediwiss 691 
Analytic, Moers, Germany) in a central laboratory.53 The atopic and non-atopic phenotypes of asthma 692 
were defined by presence or absence of concomitant sensitization to inhalant (seasonal or perennial) 693 
allergens with specific IgE ≥0.7 IU/ml at age 6 years while the reference always were children without 694 
asthma.  695 
Spirometry was performed as described previously,54 and spirometric indices were calculated 696 
according the equations of a Task Force of the European Respiratory Society (https://www.ers-697 
education.org/guidelines/global-lung-function-initiative/spirometry-tools.aspx). FEV1-values were 698 
determined as z scores and the lower quintile was defined as children with “bad lung function”. 699 
Assessment of exposures 700 
Assessment of environmental exposures by questionnaires covered pregnancy and the first year of 701 
life and included premature birth (less than 37 weeks of gestation), low birthweight (below 2500g) as 702 
well as variables for birthweight and gestational age dichotomized at the median, APGAR-score at 5 703 
minutes, and delivery mode including natural vaginal birth, vaginal birth with forceps or vacuum 704 
extraction or cesarean section. Data on treatment with systemic antibiotics was available for the first 705 
2 months and the first year beyond two months; maternal treatment with antibiotics during the first 706 
two months of lactation was also considered.  707 
Breastfeeding was defined at any breastfeeding until 2 months or current breastfeeding at month 2. 708 
Duration of breast feeding was dichotomized at various cut-off levels from 2 to 12 months. Food 709 
diversity was defined as introduction of 5 out of 6 main food items (vegetables or fruits, cereals, 710 
meat, bread, yogurt, cake) within the first year as previously described.55 In a sensitivity analysis we 711 
explored an extended list of 15 food items (main food items plus egg, fish, nut, soy, margarine, 712 
chocolate, other milk products, cow's milk, butter), which were dichotomized at at least 11 items. 713 
Furthermore, the children’s diet was assessed with respect to the type of supplemental food and its 714 
introduction in terms of at least weekly consumption.56 Farm milk consumption was defined as 715 
weekly consumption of any milk obtained directly from a farm irrespectively of boiling or skimming. 716 
Farm exposure was assessed as growing up on a farm or more specifically by regular contact to hay 717 
or stays in animal sheds including sheds with bigger animals such as cows, poultry sheds, or barns. As 718 
further environmental determinants, we assessed the number of siblings (at least two siblings), 719 
presence of pets (cats, dogs) in the respective time periods, smoking in pregnancy, and 720 
environmental smoke exposure defined as at least one cigarette smoked at home by any person per 721 
day. In addition, parental history of atopy, which is a combination of asthma, hay fever, and atopic 722 
eczema, or only asthma (maternal, paternal or of both) and high parental education (at least 723 
completion of secondary school) were included. 724 
DNA-extraction of fecal samples 725 
Fecal samples were frozen within 10 minutes from collection and stored at -20°C until further 726 
processing. At a central laboratory (THL Kuopio, Finland), DNA was extracted from the fecal samples 727 
in batches as follows: Partially defrosted fecal samples were homogenized using Stomacher® 80 728 
micro-Biomaster (Seward Ltd, UK) laboratory paddle blender (2 min at high speed). DNA was 729 
extracted from 150 mg of ice-cold homogenized fecal sample, using bead-beating method with Zymo 730 
Research fecal DNA MiniPrep™ kit (Catalog No. D6010, Zymo Research, Irvine, CA) according to the 731 
manufacturer’s instructions. The bead-beating step was done using FastPrep® FP120 homogenizer (2 732 
min at full speed 6.5 m/s). Finally, the samples were eluted with 100 µL of elution buffer D3004-4-10 733 
(Zymo Research, Freiburg, Germany). The sample extracts were kept on ice throughout the entire 734 
procedure. The extracted DNA was immediately frozen at -20°C and stored at -80°C.  735 
Sequencing analyses 736 
Amplification and sequencing of fecal samples were performed as described previously for bacterial 737 
and fungal communities.57 738 
Primers F515 (5′–NNNNNNNNGTGTGCCAGCMGCCGCGGTAA–3′) and R806 (5′–739 
GGACTACHVGGGTWTCTAAT–3′)58 were used to amplify the V4 region of the 16S rRNA gene. The 740 
forward primers had unique 8 bp barcodes (indicated by ‘N’) and a 2 bp linker sequence at the 5′ 741 
end. PCR reactions contained DNA template, 1 x GoTaq Green Master Mix (Promega), 1 mM MgCl2, 742 
and 2 pmol of each primer. Samples were amplified in triplicate PCR reactions. Conditions consisted 743 
of an initial 94 °C for 3 min followed by 25 cycles of 94 °C for 45 s, 50 °C for 60 s, and 72 °C for 90 s, 744 
and a final extension of 72 °C for 10 min.  745 
Primers BITS (5′–NNNNNNNNCTACCTGCGGARGGATCA–3′) and B58S3 (5′–746 
GAGATCCRTTGYTRAAAGTT–3′) were used to amplify fungal internal transcribed spacer region 1.59 747 
Again, the forward primers had unique 8 bp barcodes and a linker sequence (bold portion) at the 5’ 748 
end. PCR reactions contained DNA template, 1 x GoTaq Green Master Mix (Promega), 1 mM MgCl2, 749 
and 2 pmol of each primer. Reaction conditions consisted of an initial 95 °C for 2 min followed by 40 750 
cycles of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 60 s, a final extension of 72 °C for 5 min.  751 
Amplicons were run on an 0.8 % agarose gel to verify amplification by gel electrophoresis. Bacterial 752 
and fungal amplicons were combined into two separately pooled samples, purified using the 753 
Qiaquick spin kit (Qiagen), and submitted to the University of California Davis Genome Center DNA 754 
Technologies Core for Illumina paired-end library preparation, cluster generation, and 250-bp paired-755 
end sequencing on an Illumina MiSeq instrument in separate runs. 756 
Raw sequencing data from each run was demultiplexed using sabre.60 Demultiplexed data was 757 
imported into QIIME2-2018.661 and quality trimmed. Reads were denoised using DADA262 as 758 
implemented in QIIME2. Taxonomy was assigned to representative sequences using a naïve Bayes 759 
classifier63,64 pre-built from the 99% GreenGenes database65 specific to the 515F/806R region for 760 
bacterial data. For fungal sequences, a classifier was built from the UNITE dynamic database for 761 
taxonomic assignment.66 For fungal data, no tree was created because there is currently no valid 762 
taxonomy available with respect to ITS sequences.  763 
Taken sequences from 2 and 12 months together, 5,915 amplicon sequence variants (ASVs) were 764 
retrieved from 16S rRNA sequences, after excluding Chloroplasts. For ITS 54,459 ASVs were retrieved 765 
when restricted to fungi. Our analyses are reported on the genus level. If genera were not identified 766 
we used the name of the lowest identified level. If information was only available on the kingdom 767 
level we named the taxon ‘completely unidentified’. Samples with <1000 reads were removed.  768 
Genetics 769 
Genotyping for 939 children with available DNA samples in the PASTURE study was performed at the 770 
Centre National de Génotypage, Evry, France, using the iPLEX Gold technology, a matrix assisted laser 771 
desorption / ionization – time of flight (MALDI-TOF) mass spectrometry system from SEQUENOM.67 772 
Technical errors were minimized by comparing genotype frequencies with the expected allelic 773 
population equilibrium based on the Hardy-Weinberg equilibrium test. cDNA was amplified in 774 
duplicate using an iCycler (Bio-Rad Laboratories, Hercules, Calif) and 18S as reference gene. Quality 775 
checks were passed by samples of 896 children (95%). Of these, 512 children were included in the 776 
present analysis for 16S rRNA. 777 
Selection of single nucleotide polymorphisms (SNPs) was based on previous reports and included 778 
polymorphisms at the chromosome 17q21 childhood-onset asthma risk locus.68-70 Specifically, 779 
rs8076131 related to the ORMDL3 gene and rs2290400 / rs7216389 related to the GSDMB gene at 780 
this locus were found to interact for childhood asthma with environmental tobacco smoking71 and 781 
viral infections.72 SNP rs8076131 was selected for the current analysis because it has been described 782 
in the context of functional regulation.73 783 
Short chain fatty acids 784 
Metabolite levels of short-chain fatty acids (SCFA) were measured in fecal samples obtained from 785 
301 children of the PASTURE study at the age of 12 months.32 These fecal samples were processed as 786 
previously described.74 Briefly, 1 ml of 0.15 mM H2SO4 was added to 0.3 g feces to generate a fecal 787 
suspension. After rigorous vortexing, the samples were centrifuged twice (14’000 g for 30 min) and 788 
sequentially filtered through a 0.45 µm Millex-HA filter and a 0.2 µm Millex-LG filter (Merck, 789 
Darmstadt, Deutschland). The resultant fecal homogenates were analyzed by High Performance 790 
Liquid Chromatography (Merck Hitachi, Schaumburg, USA) using an Rezex ROA-Organic Acid H+ ion 791 
exchange column together with a SecurityGuard Cartidges Carbo-H from Phenomenex (Torrance, 792 
USA) at a flow rate of 0.4 ml at 40 °C with 10 mM H2SO4 as eluent solution. The samples were 793 
quantified in relation to standards.75 Of these 301 children, 209 (69%) were included in the present 794 
16S rRNA analysis (Figure S1). 795 
Relative abundance of butyryl-CoA:acetate CoA-transferase gene 796 
Relative abundance of the butyryl-CoA:acetate CoA-transferase gene was measured in a nested 1:2 797 
case-control sample of 51 asthmatics and 106 healthy controls with available fecal samples at 12 798 
months. Quantitative PCR (qPCR) primers and annealing temperatures against total bacteria (primers 799 
UniF and UniR, 0.5 µM final concentration) and the butyryl-CoA:acetate CoA-transferase gene 800 
(primers BCoATscrF and BCoATscrR, 2.5 µM final concentration) are described in Ramirez-Farias et al 801 
(2009).76 qPCR equipment and reagents are described in Reichardt et al (2018).35 DNA samples were 802 
used without further dilution unless their concentration (determined with a Qubit dsDNA HS assay 803 
kit, Thermo Fisher Scientific, Renfrew, UK) exceeded 4 ng/µl in the qPCR assay. The data are 804 
expressed as percent butyryl-CoA:acetate CoA-transferase gene copies of total bacterial 16S rRNA 805 
gene copies as detailed in Ramirez-Farias et al, 2009.76 Measurement of relative abundance of the 806 
butyryl-CoA:acetate CoA-transferase gene was performed in duplicates, and measurements were 807 
considered valid if standard deviation was below 0.4. This was necessary to eliminate technical 808 
artefacts such as air bubbles that may interfere with the optical fluorescence reading. Of all 157 809 
children selected into the case-control study, valid results were obtained in 138 individuals (88%). 810 
Data were stored in EXCEL. 811 
Statistical analysis 812 
Statistical analysis was performed with R 3.4.3 and 3.6.1 (https://www.R-project.org), particularly 813 
with package phyloseq, and MPlus (Muthén & Muthén, 1998-2012). Upon request, computer code 814 
will be made available to readers. 815 
Relative abundance was used to describe taxonomic distribution of bacteria and fungi. Rare taxa 816 
were defined by a relative abundance below 0.5% in the respective population and subsumed in a 817 
category termed “rare”. For logarithmic presentations, values were transformed by decadic 818 
logarithm; where necessary zero values were replaced by the lowest measured value. All statistical 819 
tests were performed two-sided, and an effective p-value <0.05 was considered statistically 820 
significant.  821 
Dirichlet Clustering 822 
Dirichlet multinomial mixtures (DMM) modelling was performed with R package 823 
DirichletMultinomial. We clustered the samples over both time points and as a sensitivity analysis 824 
separately for both time points. DMM bins samples on the basis of microbial community structure.77 825 
The number of clusters was determined by a local minimum of a Laplace approximation score, i.e. 5 826 
clusters over both time points and 3 clusters for the separate models. Transition between clusters 827 
was illustrated by R package Gmisc. 828 
Random Forests 829 
Random Forests regression was performed by R-package ranger to model sampling age on the basis 830 
of the relative abundance of bacterial or fungal genera present at 2 and 12 months in a subsample of 831 
133 (in case of fungi 35) healthy individuals, i.e. children without asthma, wheeze ever, or diarrhea 832 
during the first year. The models were estimated using 2000 trees and the ceiling of the square root 833 
of the number of selected variables per level.  The resulting prediction model, mainly defined by 834 
alterations in relative abundance of all genera were subsequently applied to the entire population, 835 
using the function predict of ranger. These estimates were used as a proxy for bacterial or fungal 836 
maturation and subsequently called estimated microbiome age (EMA) or estimated fungal age (EFA). 837 
To confirm that results were independent of the training sets, we performed sensitivity analyses 838 
restricting the models to children not included in model building. Taxa were ranked by their variable 839 
importance in random forest models for EMA and EFA, respectively, which discriminate best 840 
between the two measurement time points. 841 
A similar approach was used to estimate short chain fatty acids (SCFA) scores for Butyrate, 842 
Propionate, and Acetate. SCFA levels were modeled by the relative abundance of bacterial genera in 843 
children with SCFA measures available. These prediction models were applied to predict SCFA 844 
production scores in the entire population. Taxa were ranked by their variable importance in random 845 
forest models for SCFA production. The number of randomly picked variables was optimized by 10-846 
fold cross-validation. As a member of the out-of-bag methods, random forest carries the advantage 847 
over classical cross-validation that it yields an unbiased error estimate, i.e. high validity.78 As random 848 
forest integrates all information on microbial taxa in a single model no correction for multiple 849 
comparisons was necessary. Besides continuous variables, the estimated microbiome age as well as 850 
the butyrate score were also dichotomized at the lowest quartile in respective subsamples to give an 851 
estimate for a threshold phenomenon. 852 
Microbial diversity and composition 853 
Samples were rarefied at the minimum sequence numbers in the available biosamples, i.e. 1029 16s 854 
rRNA sequences and 1000 ITS sequences. Rarefaction and calculation of species richness and 855 
Shannon’s diversity index was iterated 1000 times and the resulting measures of alpha-diversity were 856 
subsequently averaged. An independent rarefying step was done in the sample of month 12 only for 857 
analyses of presence vs. absence of specific ASVs. For the assessment of the bacterial composition, 858 
the R package composition was used to perform centered-log ratio (clr) transformation after adding 859 
a pseudocount of 0.5 to abundance values. This approach developed by Aitchison was shown to be 860 
essential in microbiome analyses.79 The clr transformed abundance values were entered in principal 861 
component analyses (PCA) for assessing beta-diversity. In addition, beta-diversity was assessed by 862 
principal coordinate analyses (PCoA) on the ASV-level using unweighted UniFrac as distance measure 863 
calculated by R package GUnifrac. Samples taken at 2 months and at 12 months were evaluated 864 
separately by PCA and PCoA. In addition, PCoA was also applied in a sensitivity analysis combining all 865 
samples from both time points. Associations of indices of maturation, butyrate production, or 866 
microbial composition (as determined by PCA) with asthma or determinants were based on 867 
regression models, in which the microbial variables were usually z-standardized to render them 868 
comparable against each other. All analyses were adjusted for center. Models only adjusted for 869 
center were termed “simple models”, whereas the term “mutually adjusted models” refers to 870 
models where two exposures were compared and forced in the same model. Interaction was 871 
analyzed by including a product term in the regression models. 872 
Confirmatory analyses on estimated microbiome age and farming or asthma were replicated over 873 
study centers and assessed by a meta-analysis with fixed effects (R package rmeta). 874 
To compare indirect and direct effects, mediation models were calculated in Mplus (Muthén & 875 
Muthén, 1998-2012) and validated with the R package mediation. The mediated effect is reported as 876 
the proportion of the estimated indirect effect of the total effect.  877 
To test for associations of single taxa with asthma we first tested for differences in relative 878 
abundance by Wilcoxon test; main associations (p<0.1) were then confirmed in the clr-transformed 879 
variables with logistic regression models. These models were adjusted for center only or additional 880 
for EMA to determine single taxa effects independent of the general maturation process. Single taxa 881 
were assessed in an exploratory approach; therefore, adjustment for multiple comparisons was not 882 
performed. All statistical tests were performed two-sided.  883 
Box and whiskers plots were used as follows: lower and upper hinges denote the first and third 884 
quartiles, respectively; the bold central line represents the median; the whiskers extend to the most 885 
extreme data point within 1.5 times the interquartile range from the hinges; extreme values lie 886 
beyond the whiskers and are marked by circles. Forest plots give point estimates with 95%-887 
confidence intervals. 888 
Spearman coefficient was used to calculate any kind of correlations between different measures 889 
except for network analyses. 890 
Network analyses 891 
Correlations between pairs of bacterial genera were estimated using the SparCC approach.80 The 892 
corresponding correlation network was visualized using the R package qgraph. In the network plot, 893 
only correlations with an absolute value greater than or equal to 0.2 are shown. For readability, 894 
nodes without any connections were removed. Node sizes were scaled on the eigenvector centrality 895 
measure, which was determined via the function eigen_centrality from the R package igraph.  896 
Hubs were defined as nodes with an eigenvector centrality value greater than the 99th percentile of 897 
all eigenvector centrality values in the network. Groups of highly connected nodes, also called 898 
clusters or modules, were identified via the igraph function cluster_fast_greedy, which is a fast 899 
greedy algorithm for determining clusters via maximizing the modularity measure over all possible 900 
clusterings.81  901 
To relate the composition of the network modules to EMA and the butyrate score, we used an 902 
approach similar to the eigengene analysis,82 i.e. we used the first eigenvector of a PCA using the clr-903 
transformed taxa passing the threshold-criteria to build the network plots as representative for the 904 
respective module.  905 
Data availability 906 
Taxonomy was assigned using the GreenGenes database (greengenes.lbl.gov) for 16S rRNA 907 
sequences and the UNITE dynamic database (unite.ut.ee) for ITS sequences. All 16S rRNA and ITS 908 
sequences are deposited in the Supplementary Information without metadata. PASTURE is an 909 
ongoing birth cohort with fieldwork still being executed. As long as the study is not yet anonymized, 910 
European data protection legislation prohibits sharing of individual data, also when pseudonymized. 911 
Upon request, the authors will share aggregate data that do not allow identification of individuals. 912 
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Total effect:   -0.574  p=0.063
Indirect effect:   -0.111   p=0.011
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Total effect:  -0.571  p=0.065
Indirect effect:  -0.130  p=0.010
Direct effect: -0.441  p=0.156
Indirect effect:  -0.086
Indirect effect:  0.000
Indirect effect:  -0.036
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